The final two lanes are positive controls, consisting of lysates from a prostate cancer mobile line (LNCAP) and from cos-seven cells transfected with a indigenous entire-duration sequence of human C/EBPb (cos/b)
C/EBPa and C/EBPb expression in human pores and skin SCC. Complete protein lysates from...